Momenta Pharmaceuticals Inc (NASDAQ:MNTA)
During the Trading Day
| 13.08 |  +0.21 / +1.63% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 13.08 |  0.00 / 0.00% |
Volume: 6.5K |
Latest MNTA News | Press Releases
No recent news for Momenta Pharmaceuticals Inc.
Today’s Trading
| Previous close | 12.87 |
| Today’s open | 12.83 |
| Day’s range | 12.77 - 13.10 |
| Volume | 408,096 |
| Average volume (3 months) | 308,557 |
| Market cap | $668.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -132.68% |
| Earnings growth (this year) | -61.81% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -77.42% |
| P/E ratio | NM |
| Price/Sales | 9.30 |
| Price/Book | 1.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SZYMSolazyme Inc | +0.04 | +0.35% |
| ITMNInterMune Inc | -0.14 | -1.38% |
| PLXProtalix Biotherapeu... | +0.01 | +0.19% |
| HALOHalozyme Therapeutic... | +0.02 | +0.26% |
Data as of 4:03pm ET, 05/21/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $63.9M |
| Annual profit (last year) | -$58.6M |
| Net profit margin | -91.75% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler, MBA |
Chief Financial Officer & Senior Vice President Richard P. Shea, MBA, CPA |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
